MWM
IART icon

Mascoma Wealth Management’s Integra LifeSciences IART Stock Holding History

Mascoma Wealth Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-148
Closed -$10K – 622
2022
Q1 		$10K Hold
148
– – ﹤0.01% 439
2021
Q4 		$10K Buy
+148
New +$10K ﹤0.01% 402

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Mascoma Wealth Management's IART Position: Q2 2022 in Review

Mascoma Wealth Management sold out of Integra LifeSciences (IART) in Q2 2022, closing a stake of 148 shares — an estimated $10K sold.

Mascoma Wealth Management first reported a position in IART in Q4 2021 and held it in 2 quarters. The position peaked at $10K in Q1 2022. 284 funds tracked by Wall St. Rank hold IART as of Q2 2022.

  • Mascoma Wealth Management reported no remaining Integra LifeSciences position as of Q2 2022 after selling out during the quarter.
  • Mascoma Wealth Management sold 148 Integra LifeSciences shares in Q2 2022, an estimated $10K.
  • Mascoma Wealth Management first reported a position in Integra LifeSciences in Q4 2021 and held it in 2 quarters.
  • Mascoma Wealth Management's Integra LifeSciences position peaked at $10K in Q1 2022.
  • 284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2022.

Based on Mascoma Wealth Management's 13F filing for Q2 2022, filed 14 Jul 2022.